Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration. [PDF]
Millian DE +12 more
europepmc +1 more source
Malformin A1–mediated cytotoxicity in ovarian cancer cells occurs through pyroptosis and autophagy
This study investigated the effects of the natural compound Malformin A1 (MA1) on the cytoskeleton that regulates cell proliferation and migration. Disruption of the cytoskeleton can impair these processes and promote cancer cell death. MA1 disrupted cytoskeletal organization, induced DNA damage, inflammation, activated autophagy, and pyroptosis ...
Nada Abdullah Hassan +11 more
wiley +1 more source
AFED, a comprehensive resource for Aspergillus flavus gene expression profiling. [PDF]
Mack BM, Lebar MD.
europepmc +1 more source
From Morphology to Gene Expression Profiling in Mycosis Fungoides: Is It Still a Diagnostic Challenge? [PDF]
Filosa A +6 more
europepmc +1 more source
Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study. [PDF]
Wang L +5 more
europepmc +1 more source
A computational framework for optimizing mRNA vaccine delivery via AI-guided nanoparticle design and <i>in silico</i> gene expression profiling. [PDF]
Di Salvatore V +3 more
europepmc +1 more source
Gene expression profiling of KLF4 and KLF5 in visceral adipose tissue of obese women: insights into adipogenic and metabolic regulation. [PDF]
Muhi DJ +5 more
europepmc +1 more source
Gene expression profiling in pure neural leprosy: insights into pathogenesis and diagnostic biomarkers. [PDF]
de Athaide MM +8 more
europepmc +1 more source
Gene Expression Profiling Can Distinguish Tumor Subclasses of Breast Carcinomas
Hedenfalk, Ingrid,, Lund University.
core
Related searches:
Gene expression profiling in sarcomas
Critical Reviews in Oncology/Hematology, 2007Sarcomas are a heterogeneous group of malignant mesenchymal tumors of difficult classification. There is considerable variability in both histological appearance and responsiveness to therapy. Their overall poor clinical prognosis is reflected by the fact that >65% of patients suffering retroperitoneal soft tissue sarcoma die within 5 years [Heslin MJ,
Katharina, Tschoep +4 more
openaire +2 more sources

